VIR Vir Biotechnology
- 9.610
- -0.160-1.64%
Vir Biotechnology News
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer de Verneuil Vanina
Vir Biotechnology | 144: Notice of proposed sale of securities pursuant to Rule 144
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer de Verneuil Vanina
Vir Biotechnology | 144: Notice of proposed sale of securities pursuant to Rule 144
Vir Biotechnology | 10-Q: Q3 2024 Earnings Report
Vir Biotechnology | 8-K: Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A
Vir Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION :(4.1%)
Vir Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer O'Byrne Jason
Vir Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer Sabatini Brent
Vir Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer de Verneuil Vanina
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Napolitano Janet
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | 144: Notice of proposed sale of securities pursuant to Rule 144
Vir Biotechnology | 10-Q: Q2 2024 Earnings Report
Vir Biotechnology | 8-K: Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities
Vir Biotechnology | 8-K: Current report
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Eisner Mark
Vir Biotechnology | 144: Notice of proposed sale of securities pursuant to Rule 144
Vir Biotechnology | 8-K: Current report
Analysis
Price Target
No Data
No Data